Neil Lambie Selected Research

Cyclins

1/2023

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neil Lambie Research Topics

Disease

2	Carcinoma (Carcinomatosis) 01/2023 - 04/2022
2	Neoplasms (Cancer) 01/2023 - 04/2022
1	Endometrial Neoplasms (Endometrial Cancer) 04/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2017
1	Endocarditis 03/2003

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2022
1	Messenger RNA (mRNA)IBA 01/2023
1	CyclinsIBA 01/2023
1	16S Ribosomal RNAIBA 04/2022
1	taxaneIBA 04/2022
1	PlatinumIBA 04/2022
1	Papillomavirus Vaccines (HPV Vaccines)IBA 10/2017
1	Coloring Agents (Dyes)IBA 03/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 04/2022
1	Neoadjuvant Therapy 04/2022
1	Lasers (Laser) 10/2017
1	Therapeutics 03/2003